Sherwin-Williams Co (NYSE:SHW) Shares Purchased by Benjamin F. Edwards & Company Inc.

Share on StockTwits

Benjamin F. Edwards & Company Inc. increased its holdings in shares of Sherwin-Williams Co (NYSE:SHW) by 6.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,950 shares of the specialty chemicals company’s stock after acquiring an additional 118 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Sherwin-Williams were worth $1,138,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in SHW. Candriam Luxembourg S.C.A. grew its holdings in Sherwin-Williams by 18.7% during the fourth quarter. Candriam Luxembourg S.C.A. now owns 46,341 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 7,295 shares during the period. Manchester Financial Inc. acquired a new position in Sherwin-Williams during the fourth quarter worth $29,000. Wealthcare Advisory Partners LLC grew its holdings in Sherwin-Williams by 66.7% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 50 shares of the specialty chemicals company’s stock worth $29,000 after acquiring an additional 20 shares during the period. Heritage Wealth Advisors acquired a new stake in Sherwin-Williams in the fourth quarter valued at $34,000. Finally, Investors Research Corp grew its holdings in Sherwin-Williams by 49.2% in the third quarter. Investors Research Corp now owns 88 shares of the specialty chemicals company’s stock valued at $48,000 after purchasing an additional 29 shares during the last quarter. 76.93% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NYSE:SHW opened at $585.45 on Monday. Sherwin-Williams Co has a 52-week low of $410.35 and a 52-week high of $599.95. The stock’s fifty day simple moving average is $578.39 and its 200-day simple moving average is $559.02.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $4.27 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $4.40 by ($0.13). The firm had revenue of $4.11 billion during the quarter, compared to analyst estimates of $4.19 billion. During the same quarter in the prior year, the company earned $3.54 EPS. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. On average, equities analysts anticipate that Sherwin-Williams Co will post 23.23 EPS for the current fiscal year.

In other news, CEO John G. Morikis sold 14,734 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $576.92, for a total value of $8,500,339.28. Following the sale, the chief executive officer now directly owns 111,120 shares in the company, valued at $64,107,350.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.50% of the stock is owned by corporate insiders.

Several analysts have weighed in on SHW shares. JPMorgan Chase & Co. upped their target price on Sherwin-Williams from $490.00 to $560.00 and gave the company a “neutral” rating in a report on Wednesday, October 23rd. Citigroup lowered their target price on Sherwin-Williams from $657.00 to $650.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Goldman Sachs Group lowered Sherwin-Williams from a “buy” rating to a “neutral” rating in a report on Wednesday, November 27th. Edward Jones lowered Sherwin-Williams from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, UBS Group upped their target price on Sherwin-Williams from $570.00 to $580.00 and gave the company a “neutral” rating in a report on Friday, January 31st. Fifteen investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Sherwin-Williams presently has a consensus rating of “Hold” and an average target price of $584.52.

Sherwin-Williams Company Profile

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors and do-it-yourself homeowners.

Further Reading: Price to Earnings Ratio (PE) Basics

Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sherwin-Williams Co (NYSE:SHW).

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.